1-[2-[2-oxo-(5R)-dihydro-1H-5-pyrrolylcarboxamido]-(2S)-pentanoyl]-(5R)-dihydro-1H-5-pyrrolecarboxamide

ID: ALA2371421

Chembl Id: CHEMBL2371421

Cas Number: 78058-02-3

PubChem CID: 132489

Max Phase: Preclinical

Molecular Formula: C15H24N4O4

Molecular Weight: 324.38

Molecule Type: Protein

Associated Items:

Names and Identifiers

Canonical SMILES:  CCC[C@H](NC(=O)[C@@H]1CCC(=O)N1)C(=O)N1CCC[C@H]1C(N)=O

Standard InChI:  InChI=1S/C15H24N4O4/c1-2-4-10(18-14(22)9-6-7-12(20)17-9)15(23)19-8-3-5-11(19)13(16)21/h9-11H,2-8H2,1H3,(H2,16,21)(H,17,20)(H,18,22)/t9-,10-,11-/m0/s1

Standard InChI Key:  YWZAPMXAANPWLC-DCAQKATOSA-N

Alternative Forms

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TRHDE Thyrotropin releasing hormone degrading enzyme (95 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 324.38Molecular Weight (Monoisotopic): 324.1798AlogP: -0.97#Rotatable Bonds: 6
Polar Surface Area: 121.60Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 11.44CX Basic pKa: CX LogP: -1.53CX LogD: -1.53
Aromatic Rings: Heavy Atoms: 23QED Weighted: 0.58Np Likeness Score: -0.46

References

1. Szirtes T, Kisfaludy L, Pálosi E, Szporny L..  (1984)  Synthesis of thyrotropin-releasing hormone analogues. 1. Complete dissociation of central nervous system effects from thyrotropin-releasing activity.,  27  (6): [PMID:6429332] [10.1021/jm00372a006]
2.  (2010)  TRH-like peptide derivatives as inhibitors of the TRH-degrading ectoenzyme,